Professor Rhiannon Tudor Edwards
Professor in Health Economics
Contact info
Founding director of health economics research at Bangor University. Co-director of the Centre for Health Economics and Medicines Evaluation (CHEME) at Bangor University.
In a global analysis of bibliometrics in health economics (1975-2022), Rhiannon was listed among the most important authors in health economics. She was ranked in the top five most collaborative authors, with Bangor University in the top 10 most collaborative institutions in health economics. See: Barbu, L. Global trends in the scientific research of the health economics: a bibliometric analysis from 1975 to 2022. Health Econ Rev 13, 31 (2023).
Telephone: +44 (0) 1248 383 712
E-mail: r.t.edwards@bangor.ac.uk
Address: Room 103, Ardudwy, Normal Site, Bangor University, Bangor, Gwynedd LL57 2PZ
X (formerly known as Twitter): @ProfRTEdwards
- Published
What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid review
Spencer, L., Hendry, A., Makanjuola, A., Anthony, B., Davies, J., Pisavadia, K., Hughes, D., Fitzsimmons, D., Wilkinson, C., Edwards, R. T., Lewis, R., Cooper, A. & Edwards, A., 28 Jan 2023, 34 p. (MedRxiv).Research output: Working paper › Preprint
- Published
What is the long-term impact of COVID-19 on the Health-Related Quality of Life of individuals with mild symptoms (or non-hospitalised): A rapid review
Spencer, L., Hendry, A., Makanjuola, A., Davies, J., Pisavadia, K., Hughes, D., Fitzsimmons, D., Wilkinson, C., Edwards, R. T., Lewis, R., Cooper, A. & Edwards, A., 9 Sept 2022, Health and Care Research Wales, 47 p.Research output: Working paper › Preprint
- Published
RES00019. Wales COVID-19 Evidence Centre. A rapid evidence summary indicating the evidence of the inverse care law in social care in Wales and has this been exacerbated by the COVID-19 pandemic?
Spencer, L., Hendry, A., Makanjuola, A., Hughes, D., Wilkinson, C., Pisavadia, K., Davies, J., Fitzsimmons, D. & Edwards, R. T., Feb 2022, Welsh Government. 33 p.Research output: Book/Report › Other report
- Published
Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff? Report number: RR_00018 (November 2021)
Spencer, L., Hartfiel, N., Hendry, A., Anthony, B., Makanjuola, A., Bray, N., Hughes, D., Wilkinson, C., Fitzsimmons, D. & Edwards, R. T., 1 Nov 2021, 36 p.Research output: Book/Report › Other report › peer-review
- Published
Developing and evaluating a child-centred intervention for diabetes medicine management using mixed methods and a multicentre randomised controlled trial
Spencer, L. H., Sylvestre Garcia, G. Y., Yeo, S. T., Noyes, J., Lowes, L., Whitaker, R., Allen, D., Carter, C., Edwards, R. T., Rycroft-Malone, J., Sharp, J., Edwards, D., Spencer, L., Sylvestre, Y., Yeo, S. & Gregory, J., 1 Mar 2014, In: Health Services and Delivery Research. 2, 8, p. -Research output: Contribution to journal › Article › peer-review
- Published
The QALY at 50: One story many voices
Spencer, A., Rivero-Arias, O., Wong, R., Tsuchiya, A., Bleichrodt, H., Edwards, R. T., Norman, R., Lloyd, A. & Clarke, P., Mar 2022, In: Social Science and Medicine. 296, 114653.Research output: Contribution to journal › Article › peer-review
- Published
STRAWB2 (Stress and Wellbeing After Childbirth): a randomised controlled trial of targeted self-help materials to prevent post-traumatic stress disorder following childbirth
Slade, P., West, H., Thompson, G., Lane, S., Spiby, H., Edwards, R. T., Charles, J., Garrett, C., Flanagan, B., Treadwell, M., Hayden, E. & Weeks, A., Jun 2020, In: BJOG: an international journal of obstetrics and gynaecology . 127, 7, p. 886-896 11 p.Research output: Contribution to journal › Article › peer-review
- Published
Social Return on Investment of Social Prescribing via a Diabetes Technician for Preventing Type 2 Diabetes Progression
Skinner, A., Hartfiel, N., Lynch, M., Jones, A. W. & Edwards, R. T., 7 Jun 2023, In: International Journal of Environmental Research and Public Health. 20, 12, 6074.Research output: Contribution to journal › Article › peer-review
- Published
Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial
Sivaprasad, S., Prevost, A. T., Bainbridge, J., Edwards, R. T., Hopkins, D., Kelly, J., Luthert, P., Murphy, C., Ramu, J., Sarafraz-Shekary, N., Vasconcelos, J. W. & Hykin, P., 14 Sept 2015, In: BMJ Open. 5, 9Research output: Contribution to journal › Article › peer-review
- Published
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Sivaprasad, S., Prevost, A. T., Vasconcelos, J. C., A, R., Murphy, C., Kelly, J., J, B., Edwards, R. T., Hopkins, D. & Hykin, P., 3 Jun 2017, In: The Lancet. 389, 10085, p. 2193-2203Research output: Contribution to journal › Article › peer-review